Upper Abdominal Health Screening Package

US$1,402
NT$45,000 · you pay the hospital in NT$
Book this checkup

Prefer to book it yourself? Call Eonway Health Management Center on (02)2332-9888 or use its English site ↗. It's free; most hospitals take bookings in Chinese.

We book it with the hospital for you, from US$149, paid only after the hospital confirms. We reply by email with available dates, the confirmed price, and whether an English report is available.

Paying from a US account? HSA and FSA notes.

Share on LINE / 分享到 LINE

As published by the hospital · checked 2026-09-20

A specialty-tier program with Abdominal MRI / MRCP, Low-dose chest CT, Nasopharyngoscopy, Abdominal ultrasound and Breast ultrasound and a 66-test panel, with a doctor's review at the end.

Takes
One day, no overnight
Sedation
Not offered
English report
Ask the hospital (we ask for you in Book it for me)

What stands out

Abdominal MRI / MRCP

Liver, pancreas and bile duct tumors and disease.

Low-dose chest CT

Early lung cancer; the USPSTF recommends it yearly for some adults 50 to 80 with a heavy smoking history.

Nasopharyngoscopy

Nasopharyngeal and throat abnormalities.

Abdominal ultrasound

Liver (fatty liver, tumors), gallbladder stones, pancreas, spleen and kidneys.

Every test, in English

66 tests listed, 61 of them on our shared test list, so they line up against other hospitals' packages.

Vitals6
Blood Count2
Liver Function8
Kidney & Electrolytes4
Lipids & Cardiometabolic6
Glucose3
Thyroid & Endocrine2
Tumor Markers5
Infection Serology3
Urine & Stool2
Cardiac2
Ultrasound6
CT Imaging1
MRI Imaging1
Endoscopy1
Women's Health2
Bone & Body Composition1
Eye1
ENT & Dental1
Consultation4
Show all 66 tests and what each screens for
TestScreens forAdd-on?
Vitals
Blood pressureScreens for hypertension, a major risk factor for heart disease and stroke.Incl.
Body composition analysisBody fat, muscle mass and water percentage.Incl.
Height, weight and BMIBasic body measurements used to assess weight-related health risk.Incl.
Pulse oximetryBlood oxygen level.Incl.
Basic vital signs (pulse, temperature, respiration)Basic pulse, temperature and breathing rate measurements taken during a checkup.Incl.
Waist circumferenceCentral obesity, a marker of metabolic risk.Incl.
Blood Count
Complete blood countAnemia, infection and blood cell disorders.Incl.
White blood cell differentialBreakdown of white cell types; infection, allergy and some blood cancers.Incl.
Liver Function
AlbuminLiver function and nutrition status.Incl.
Alkaline phosphataseLiver, bile duct and bone conditions.Incl.
ALT (SGPT)Liver cell damage; the most common liver screening test.Incl.
AST (SGOT)Liver cell damage.Incl.
Direct bilirubinBile duct obstruction.Incl.
Globulin and A/G ratioImmune protein levels.Incl.
Total bilirubinJaundice, liver and bile problems.Incl.
Total proteinNutrition and liver/kidney protein handling.Incl.
Kidney & Electrolytes
Blood urea nitrogenKidney function.Incl.
CreatinineKidney function.Incl.
Estimated GFRKidney filtering capacity; stages chronic kidney disease.Incl.
Uric acidGout risk and kidney stone risk.Incl.
Lipids & Cardiometabolic
Total cholesterol / HDL ratioA calculated ratio of total cholesterol to HDL cholesterol used in some cardiovascular risk calculators.Incl.
HDL cholesterolProtective cholesterol level.Incl.
HomocysteineCardiovascular risk marker.Incl.
LDL cholesterolThe main cholesterol driving heart disease risk.Incl.
Total cholesterolCardiovascular risk.Incl.
TriglyceridesCardiovascular and pancreatitis risk.Incl.
Glucose
Fasting glucoseDiabetes and prediabetes.Incl.
Hemoglobin A1cAverage blood sugar over the past three months; diabetes.Incl.
Fasting insulinInsulin resistance.Incl.
Thyroid & Endocrine
Free T4Thyroid hormone level.Incl.
TSHThyroid function; the primary thyroid screening test.Incl.
Tumor Markers
AFPLiver cancer marker (also used with liver ultrasound in hepatitis B carriers).Incl.
CA-125Ovarian cancer marker.Incl.
CA 19-9Pancreatic and biliary cancer marker.Incl.
CEAColorectal and other GI cancer marker.Incl.
PSAProstate cancer marker.Incl.
Infection Serology
Hepatitis B surface antibodyImmunity to hepatitis B (from vaccine or past infection).Incl.
Hepatitis C antibodyHepatitis C infection.Incl.
Hepatitis B surface antigenCurrent hepatitis B infection; very common in Taiwan.Incl.
Urine & Stool
Stool occult blood (FIT)Colorectal cancer and polyps; the standard non-invasive colon screen.Incl.
UrinalysisKidney disease, urinary infection, diabetes.Incl.
Cardiac
10-year cardiovascular risk scoreA calculated estimate of your 10-year risk of heart attack or stroke based on your risk factors.Incl.
Resting ECGHeart rhythm and signs of prior heart damage.Incl.
Ultrasound
Abdominal ultrasoundLiver (fatty liver, tumors), gallbladder stones, pancreas, spleen and kidneys.Incl.
Breast ultrasoundBreast lumps; complements mammography, especially in dense breasts.Add-on
Carotid ultrasoundPlaque in the neck arteries; stroke risk.Incl.
Liver elastography (FibroScan)Liver scarring and fat without a biopsy.Incl.
Pelvic (gynecologic) ultrasoundUterus and ovary abnormalities (fibroids, cysts).Incl.
Prostate ultrasoundProstate size and abnormalities.Incl.
CT Imaging
Low-dose chest CTEarly lung cancer; the USPSTF recommends it yearly for some adults 50 to 80 with a heavy smoking history.Incl.
MRI Imaging
Abdominal MRI / MRCPLiver, pancreas and bile duct tumors and disease.Incl.
Endoscopy
NasopharyngoscopyNasopharyngeal and throat abnormalities.Incl.
Women's Health
MammographyBreast cancer; the standard screen for women 40+.Add-on
Pap smearCervical cancer and precancer.Incl.
Bone & Body Composition
Bone density (DXA)Osteoporosis and fracture risk.Incl.
Eye
Visual acuityVision sharpness.Incl.
ENT & Dental
ENT examinationEar, nose and throat abnormalities.Incl.
Consultation
Health history questionnaireFamily history and lifestyle risk assessment.Incl.
Nutrition consultationDiet advice based on your results.Incl.
Physician physical examinationA doctor's hands-on examination and history taking.Incl.
Physician consultation and report reviewA doctor explains your results and what to do next.Incl.
Vitals
Blood pressureIncl.
Screens for hypertension, a major risk factor for heart disease and stroke.
Body composition analysisIncl.
Body fat, muscle mass and water percentage.
Height, weight and BMIIncl.
Basic body measurements used to assess weight-related health risk.
Pulse oximetryIncl.
Blood oxygen level.
Basic vital signs (pulse, temperature, respiration)Incl.
Basic pulse, temperature and breathing rate measurements taken during a checkup.
Waist circumferenceIncl.
Central obesity, a marker of metabolic risk.
Blood Count
Complete blood countIncl.
Anemia, infection and blood cell disorders.
White blood cell differentialIncl.
Breakdown of white cell types; infection, allergy and some blood cancers.
Liver Function
AlbuminIncl.
Liver function and nutrition status.
Alkaline phosphataseIncl.
Liver, bile duct and bone conditions.
ALT (SGPT)Incl.
Liver cell damage; the most common liver screening test.
AST (SGOT)Incl.
Liver cell damage.
Direct bilirubinIncl.
Bile duct obstruction.
Globulin and A/G ratioIncl.
Immune protein levels.
Total bilirubinIncl.
Jaundice, liver and bile problems.
Total proteinIncl.
Nutrition and liver/kidney protein handling.
Kidney & Electrolytes
Blood urea nitrogenIncl.
Kidney function.
CreatinineIncl.
Kidney function.
Estimated GFRIncl.
Kidney filtering capacity; stages chronic kidney disease.
Uric acidIncl.
Gout risk and kidney stone risk.
Lipids & Cardiometabolic
Total cholesterol / HDL ratioIncl.
A calculated ratio of total cholesterol to HDL cholesterol used in some cardiovascular risk calculators.
HDL cholesterolIncl.
Protective cholesterol level.
HomocysteineIncl.
Cardiovascular risk marker.
LDL cholesterolIncl.
The main cholesterol driving heart disease risk.
Total cholesterolIncl.
Cardiovascular risk.
TriglyceridesIncl.
Cardiovascular and pancreatitis risk.
Glucose
Fasting glucoseIncl.
Diabetes and prediabetes.
Hemoglobin A1cIncl.
Average blood sugar over the past three months; diabetes.
Fasting insulinIncl.
Insulin resistance.
Thyroid & Endocrine
Free T4Incl.
Thyroid hormone level.
TSHIncl.
Thyroid function; the primary thyroid screening test.
Tumor Markers
AFPIncl.
Liver cancer marker (also used with liver ultrasound in hepatitis B carriers).
CA-125Incl.
Ovarian cancer marker.
CA 19-9Incl.
Pancreatic and biliary cancer marker.
CEAIncl.
Colorectal and other GI cancer marker.
PSAIncl.
Prostate cancer marker.
Infection Serology
Hepatitis B surface antibodyIncl.
Immunity to hepatitis B (from vaccine or past infection).
Hepatitis C antibodyIncl.
Hepatitis C infection.
Hepatitis B surface antigenIncl.
Current hepatitis B infection; very common in Taiwan.
Urine & Stool
Stool occult blood (FIT)Incl.
Colorectal cancer and polyps; the standard non-invasive colon screen.
UrinalysisIncl.
Kidney disease, urinary infection, diabetes.
Cardiac
10-year cardiovascular risk scoreIncl.
A calculated estimate of your 10-year risk of heart attack or stroke based on your risk factors.
Resting ECGIncl.
Heart rhythm and signs of prior heart damage.
Ultrasound
Abdominal ultrasoundIncl.
Liver (fatty liver, tumors), gallbladder stones, pancreas, spleen and kidneys.
Breast ultrasoundAdd-on
Breast lumps; complements mammography, especially in dense breasts.
Carotid ultrasoundIncl.
Plaque in the neck arteries; stroke risk.
Liver elastography (FibroScan)Incl.
Liver scarring and fat without a biopsy.
Pelvic (gynecologic) ultrasoundIncl.
Uterus and ovary abnormalities (fibroids, cysts).
Prostate ultrasoundIncl.
Prostate size and abnormalities.
CT Imaging
Low-dose chest CTIncl.
Early lung cancer; the USPSTF recommends it yearly for some adults 50 to 80 with a heavy smoking history.
MRI Imaging
Abdominal MRI / MRCPIncl.
Liver, pancreas and bile duct tumors and disease.
Endoscopy
NasopharyngoscopyIncl.
Nasopharyngeal and throat abnormalities.
Women's Health
MammographyAdd-on
Breast cancer; the standard screen for women 40+.
Pap smearIncl.
Cervical cancer and precancer.
Bone & Body Composition
Bone density (DXA)Incl.
Osteoporosis and fracture risk.
Eye
Visual acuityIncl.
Vision sharpness.
ENT & Dental
ENT examinationIncl.
Ear, nose and throat abnormalities.
Consultation
Health history questionnaireIncl.
Family history and lifestyle risk assessment.
Nutrition consultationIncl.
Diet advice based on your results.
Physician physical examinationIncl.
A doctor's hands-on examination and history taking.
Physician consultation and report reviewIncl.
A doctor explains your results and what to do next.
Also listed: Fitness assessment and consultation, Oxidized LDL (oxLDL), Senior specialist one-on-one consultation and report review with printed report and health education booklet, Small dense LDL (sdLDL), Urology consultation with external genitalia examination.

Before you book

SedationNot offered
If something is foundAsk the hospital how any findings are explained, on the day or at a follow-up appointment; in Book it for me we ask for you and tell you before you book. Your own doctor decides what to do next; we do not arrange treatment.
Results and imagingAsk the hospital how long results take and how imaging is delivered; in Book it for me we ask for you and tell you before you book.
Eonway Health Management Center
Taipei · Zhongshan

On the OCAC i僑卡 partner list. Card holders can ask the center about a discount.

9 packages listed

About this hospital

What the center says

From the center's own pages, in English. Each statement links to its source.

Booking and payment
  • Online booking is available, and the center asks visitors to book at least one month in advance.

    Source ↗ · checked 2026-09-20

  • The center charges NT$200 for an original Chinese-language diagnosis certificate (NT$50 for a duplicate).

    Source ↗ · checked 2026-09-26

  • The center charges NT$300 for an original English-language diagnosis certificate (NT$100 for a duplicate).

    Source ↗ · checked 2026-09-26

  • The center charges NT$50 for an additional receipt requested at its counter.

    Source ↗ · checked 2026-09-26

  • The center accepts cash, bank transfer, and credit card as payment methods.

    Source ↗ · checked 2026-09-26

  • The checkup service operates Monday to Saturday, 07:30 to 19:00.

    Source ↗ · checked 2026-09-26

  • The center asks patients to call at least 10 days before the exam date to reschedule or cancel.

    Source ↗ · checked 2026-09-26

Before and on the day
  • Patients must begin fasting from midnight on the day of the exam, except for medications.

    Source ↗ · checked 2026-09-26

  • Patients on diabetes medication are asked not to take or inject it the morning of the exam, but to bring it and take it after the fasting tests are completed.

    Source ↗ · checked 2026-09-26

  • Patients on hypertension medication are asked to take it as usual the morning of the exam; a small amount of water for the medication does not affect the results.

    Source ↗ · checked 2026-09-26

  • Patients are asked not to wear contact lenses for the exam.

    Source ↗ · checked 2026-09-26

  • Patients are asked not to wear underwear containing metal, to avoid affecting X-ray reading.

    Source ↗ · checked 2026-09-26

  • Patients on anticoagulants or antiplatelet drugs (such as Bokey, Aspirin Protect, Plavix, Coumadin, Dabigatran, Rivaroxaban, Apixaban, Edoxaban) or blood-thinning herbs like ginkgo or fish oil are asked to stop them 3 to 7 days before the exam date.

    Source ↗ · checked 2026-09-26

  • Patients who are pregnant or possibly pregnant are asked to postpone the exam.

    Source ↗ · checked 2026-09-26

  • Patients who are on their period are asked to postpone the exam.

    Source ↗ · checked 2026-09-26

  • Patients with a pacemaker, cerebral vascular clips/coils, an artificial heart valve, a cochlear implant, or metal fragment/bullet injuries are asked to tell staff, since these are not suitable for MRI.

    Source ↗ · checked 2026-09-26

  • For coronary CT angiography and upper-abdomen CT, which require a contrast injection, patients are asked to fast (excluding water) for at least 4 hours before the exam.

    Source ↗ · checked 2026-09-26

Ask your own doctor before changing any medicine.

Results
  • A senior specialist physician gives a same-day, one-on-one explanation of the results, and a second consultation is arranged once the full report is ready.

    Source ↗ · checked 2026-09-20

  • The center says it makes routine follow-up phone calls to track abnormal results from the health check report.

    Source ↗ · checked 2026-09-20

  • The center provides an imaging cloud for online reading and sharing of medical images.

    Source ↗ · checked 2026-09-20

  • Health check reports can be viewed online through the center's own portal.

    Source ↗ · checked 2026-09-20

  • The center says the checkup report takes about three weeks to complete before it is sent out by courier.

    Source ↗ · checked 2026-09-26

  • The center mails the checkup report by courier, mainly within Taiwan; overseas postage is charged separately.

    Source ↗ · checked 2026-09-26

  • The center says it will send the checkup report to the visitor's email, or it can be viewed via the Eonway Health app.

    Source ↗ · checked 2026-09-26

Add to this package

Tests this center prices separately that this package does not include.

TestPriceNote
HPV DNA testas listed: HPV genotyping test
US$22
NT$700
For women · Only charged extra when the package does not already include a gynecology consultation.

Source ↗ · checked 2026-09-20

US price context

Bought one by one at US cash-pay marketplaces, the tests we could price list at about US$4,110–5,570 for a woman (56 of 57 tests) and US$4,474–5,834 for a man (55 of 56 tests) (MDsave, Quest and others; checked 2026-10-11).

How we priced it

A panel counts once however many of its tests the package lists. A test for one sex only is counted only for that sex. Tests we could not price are left out, so this is not what a US checkup would cost. Prices marked "rough" come from a single reseller or are extrapolated from a similar test.

Radiation from this package's imaging

About 1.5 mSv from the tests we could identify, a typical adult dose for these exams: roughly 6 months of natural background radiation (about 3 mSv a year, US average).

This package also lists 5 items we have not matched to a test; if any of them is an X-ray, CT or PET scan, the total is higher.

  • Bone density (DXA) · about less than 0.01 mSv
  • Low-dose chest CT · about 1.5 mSv

Optional add-ons would add: Mammography (about 0.28 mSv).

Typical doses from published references (RadiologyInfo.org ↗, Mettler et al. 2008 ↗); the actual dose depends on the scanner and protocol. Ask the center for its own figure.

What US screening guidelines say

The US Preventive Services Task Force is an independent US panel whose recommendations cover people without symptoms. Shown for comparison; it is not advice for you.

What US screening guidelines say about 26 of these tests
Recommended (grade A/B)The USPSTF recommends screening all adults aged 18 to 79 years for hepatitis C virus infection. (2020) · USPSTF ↗
Recommended (grade A/B)The USPSTF recommends screening for hypertension in adults 18 years or older with office blood pressure measurement, confirmed with measurement outside the clinical setting before starting treatment. (2021) · USPSTF ↗
Recommended (grade A/B)The USPSTF recommends screening for osteoporosis with bone density testing in postmenopausal women younger than 65 years who are at increased risk, based on a clinical risk-assessment tool. (2025) · USPSTF ↗
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for osteoporosis in men. (2025) · USPSTF ↗
Recommended (grade A/B)The USPSTF recommends screening for osteoporosis with bone density testing in women 65 years or older. (2025) · USPSTF ↗
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of supplemental screening with breast ultrasound in women found to have dense breasts on an otherwise negative screening mammogram. (2024) · USPSTF ↗ Note: Same I statement covers ultrasound and MRI as supplemental tests; see mri_breast. The USPSTF breast cancer screening statement does not apply to people at high risk of breast cancer (for example BRCA1/2 carriers or others with a high-risk genetic marker or syndrome, people who had high-dose chest radiation at a young age, or people with previous breast cancer or a high-risk breast lesion).
Recommended against (grade D)The USPSTF recommends against screening for ovarian cancer in asymptomatic women, including with the CA-125 blood test. (2018) · USPSTF ↗ Note: Same D-grade recommendation covers CA-125 and transvaginal/pelvic ultrasound; see pelvic_ultrasound.
Recommended against (grade D)The USPSTF recommends against screening for pancreatic cancer in asymptomatic average-risk adults. (2019) · USPSTF ↗ Note: The recommendation states there are currently no accurate, validated biomarkers for early detection of pancreatic cancer and that the USPSTF does not recommend screening the general population by any method; it does not name CA 19-9. The D grade applies to screening this population by any method, not to CA 19-9 as a separately graded test. It does not apply to people at high risk because of an inherited genetic syndrome or familial pancreatic cancer.
Recommended against (grade D)The USPSTF recommends against screening for asymptomatic carotid artery stenosis in the general adult population. (2021) · USPSTF ↗
Recommended (grade A/B)The USPSTF recommends that clinicians prescribe a statin for the primary prevention of cardiovascular disease for adults aged 40 to 75 years who have 1 or more cardiovascular risk factors and an estimated 10-year cardiovascular risk of 10% or greater. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for calculating the score. The USPSTF tells clinicians to estimate 10-year cardiovascular risk with a risk estimator (it names the ACC/AHA Pooled Cohort Equations) as a step in the statin decision. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
Selective (grade C)The USPSTF recommends that clinicians selectively offer a statin for the primary prevention of cardiovascular disease for adults aged 40 to 75 years who have 1 or more cardiovascular risk factors and an estimated 10-year cardiovascular risk of 7.5% to less than 10%. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for calculating the score. The USPSTF tells clinicians to estimate 10-year cardiovascular risk with a risk estimator (it names the ACC/AHA Pooled Cohort Equations) as a step in the statin decision. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of starting a statin for the primary prevention of cardiovascular disease in adults 76 years or older. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for calculating the score. The USPSTF tells clinicians to estimate 10-year cardiovascular risk with a risk estimator (it names the ACC/AHA Pooled Cohort Equations) as a step in the statin decision. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
Recommended (grade A/B)The USPSTF recommends screening for prediabetes and type 2 diabetes, including with a fasting plasma glucose test, in adults aged 35 to 70 years who have overweight or obesity. (2021) · USPSTF ↗ Note: Same recommendation names fasting plasma glucose, HbA1c and the oral glucose tolerance test as acceptable screening tests. The USPSTF suggests clinicians consider screening at an earlier age in groups with higher diabetes prevalence, including Asian American persons, and at a lower BMI (23 or higher) in Asian American persons.
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for thyroid dysfunction in nonpregnant, asymptomatic adults. (2015) · USPSTF ↗ Note: The I statement concerns screening for thyroid dysfunction, for which the USPSTF names serum TSH as the primary screening test; T4 is described as follow-up testing after a persistently abnormal TSH.
Recommended (grade A/B)The USPSTF recommends screening for prediabetes and type 2 diabetes, including with a hemoglobin A1c test, in adults aged 35 to 70 years who have overweight or obesity. (2021) · USPSTF ↗ Note: Same recommendation names fasting plasma glucose, HbA1c and the oral glucose tolerance test as acceptable screening tests. The USPSTF suggests clinicians consider screening at an earlier age in groups with higher diabetes prevalence, including Asian American persons, and at a lower BMI (23 or higher) in Asian American persons.
Recommended (grade A/B)The USPSTF recommends screening for hepatitis B virus infection, with an HBsAg test followed by confirmatory testing, in adolescents and adults at increased risk for infection. (2020) · USPSTF ↗ Note: Risk groups include people born in a country with HBV prevalence of 2% or more, US-born people not vaccinated as infants whose parents were born in regions with very high HBV prevalence (8% or more), people with HIV, people who inject drugs, men who have sex with men, and household or sexual contacts of someone with HBV. The recommendation names regions by prevalence, not countries.
Recommended (grade A/B)The USPSTF recommends that clinicians prescribe a statin for the primary prevention of cardiovascular disease for adults aged 40 to 75 years who have 1 or more cardiovascular risk factors and an estimated 10-year cardiovascular risk of 10% or greater. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for the cholesterol test; the USPSTF does not grade cholesterol testing on its own. The USPSTF says the ACC/AHA Pooled Cohort Equations may be used to estimate 10-year risk; per the 2013 ACC/AHA risk-assessment guideline, those equations use total and HDL cholesterol as inputs. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
Selective (grade C)The USPSTF recommends that clinicians selectively offer a statin for the primary prevention of cardiovascular disease for adults aged 40 to 75 years who have 1 or more cardiovascular risk factors and an estimated 10-year cardiovascular risk of 7.5% to less than 10%. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for the cholesterol test; the USPSTF does not grade cholesterol testing on its own. The USPSTF says the ACC/AHA Pooled Cohort Equations may be used to estimate 10-year risk; per the 2013 ACC/AHA risk-assessment guideline, those equations use total and HDL cholesterol as inputs. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of starting a statin for the primary prevention of cardiovascular disease in adults 76 years or older. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for the cholesterol test; the USPSTF does not grade cholesterol testing on its own. The USPSTF says the ACC/AHA Pooled Cohort Equations may be used to estimate 10-year risk; per the 2013 ACC/AHA risk-assessment guideline, those equations use total and HDL cholesterol as inputs. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
Recommended (grade A/B)The USPSTF recommends that clinicians offer or refer adults with a body mass index of 30 or higher to intensive, multicomponent behavioral weight-loss interventions. (2018; an update is in progress) · USPSTF ↗ Note: The grade applies to offering or referring adults with a BMI of 30 or higher to intensive behavioral weight-loss programs, not to measuring height, weight or BMI; the USPSTF says screening for obesity is now part of routine clinical practice and was not a focus of its review. The USPSTF lists an update in progress, folded into a combined topic on healthy diet, physical activity and weight loss to prevent cardiovascular disease; the 2018 statement remains the current final recommendation as of 2026-09-25.
Recommended (grade A/B)The USPSTF recommends annual screening for lung cancer with low-dose CT in adults aged 50 to 80 years with a 20 pack-year smoking history who currently smoke or quit within the past 15 years. (2021) · USPSTF ↗ Note: Screening should stop once the person has not smoked for 15 years or develops a health problem that substantially limits life expectancy or the ability to have curative lung surgery.
Recommended (grade A/B)The USPSTF recommends biennial screening mammography for women aged 40 to 74 years. (2024) · USPSTF ↗ Note: The USPSTF breast cancer screening statement does not apply to people at high risk of breast cancer (for example BRCA1/2 carriers or others with a high-risk genetic marker or syndrome, people who had high-dose chest radiation at a young age, or people with previous breast cancer or a high-risk breast lesion).
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening mammography in women 75 years or older. (2024) · USPSTF ↗ Note: The USPSTF breast cancer screening statement does not apply to people at high risk of breast cancer (for example BRCA1/2 carriers or others with a high-risk genetic marker or syndrome, people who had high-dose chest radiation at a young age, or people with previous breast cancer or a high-risk breast lesion).
Recommended against (grade D)The USPSTF recommends against screening for pancreatic cancer in asymptomatic average-risk adults. (2019) · USPSTF ↗ Note: The USPSTF does not recommend screening the general population for pancreatic cancer by any method; it mentions MRI only as one of the imaging methods studied in people at high risk. The D grade covers the pancreatic-cancer part of an abdominal MRI only, not the liver or bile duct parts of the scan. It does not apply to people at high risk because of an inherited genetic syndrome or familial pancreatic cancer.
Recommended against (grade D)The USPSTF recommends against screening for cervical cancer in women younger than 21 years. (2018; an update is in progress) · USPSTF ↗
Recommended against (grade D)The USPSTF recommends against screening for cervical cancer in women who have had a hysterectomy with removal of the cervix and do not have a history of a high-grade precancerous lesion (CIN 2 or 3) or cervical cancer. (2018; an update is in progress) · USPSTF ↗
Recommended (grade A/B)The USPSTF recommends screening for cervical cancer every 3 years with cervical cytology alone in women aged 21 to 29 years. (2018; an update is in progress) · USPSTF ↗ Note: A draft update was posted December 10, 2024 (public comment to January 13, 2025); not yet a new final recommendation as of 2026-09-25.
Recommended (grade A/B)The USPSTF recommends screening for cervical cancer in women aged 30 to 65 years, every 3 years with cytology alone, every 5 years with high-risk HPV testing alone, or every 5 years with HPV testing combined with cytology. (2018; an update is in progress) · USPSTF ↗ Note: A draft update was posted December 10, 2024 (public comment to January 13, 2025); not yet a new final recommendation as of 2026-09-25.
Recommended against (grade D)The USPSTF recommends against screening for cervical cancer in women older than 65 years who have had adequate prior negative screening and are not otherwise at high risk. (2018; an update is in progress) · USPSTF ↗
Recommended against (grade D)The USPSTF recommends against screening for ovarian cancer in asymptomatic women, including with transvaginal ultrasound. (2018) · USPSTF ↗ Note: Same D-grade recommendation covers pelvic/transvaginal ultrasound and the CA-125 blood test; see ca125. This csv does not map pelvic_ultrasound to any recommendation about non-ovarian pelvic findings (fibroids, cysts), which the USPSTF does not address.
Selective (grade C)The USPSTF says the decision to undergo periodic PSA-based screening for prostate cancer should be an individual one for men aged 55 to 69 years. (2018; an update is in progress) · USPSTF ↗ Note: The USPSTF lists an update of this topic as in progress; the 2018 statement remains the current final recommendation as of 2026-09-25.
Recommended against (grade D)The USPSTF recommends against PSA-based screening for prostate cancer in men 70 years or older. (2018; an update is in progress) · USPSTF ↗ Note: The USPSTF lists an update of this topic as in progress; the 2018 statement remains the current final recommendation as of 2026-09-25.
Recommended against (grade D)The USPSTF recommends against screening with resting or exercise ECG to prevent cardiovascular disease events in asymptomatic adults at low risk of CVD events. (2018) · USPSTF ↗
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening with resting or exercise ECG to prevent cardiovascular disease events in adults at intermediate or high risk of CVD events. (2018) · USPSTF ↗
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for atrial fibrillation with ECG in adults 50 years or older. (2022) · USPSTF ↗
Recommended (grade A/B)The USPSTF recommends screening for colorectal cancer in adults aged 45 to 49 years, including with an annual stool test for occult blood (FIT or high-sensitivity gFOBT). (2021) · USPSTF ↗ Note: Applies to asymptomatic adults at average risk of colorectal cancer: no prior colorectal cancer, adenomatous polyps or inflammatory bowel disease, and no personal diagnosis or family history of a known genetic disorder that carries a high lifetime risk, such as Lynch syndrome or familial adenomatous polyposis.
Recommended (grade A/B)The USPSTF recommends screening for colorectal cancer in all adults aged 50 to 75 years, including with an annual stool test for occult blood (FIT or high-sensitivity gFOBT). (2021) · USPSTF ↗ Note: Applies to asymptomatic adults at average risk of colorectal cancer: no prior colorectal cancer, adenomatous polyps or inflammatory bowel disease, and no personal diagnosis or family history of a known genetic disorder that carries a high lifetime risk, such as Lynch syndrome or familial adenomatous polyposis.
Selective (grade C)The USPSTF recommends that clinicians selectively offer colorectal cancer screening, including with an annual stool test for occult blood (FIT or high-sensitivity gFOBT), to adults aged 76 to 85 years based on overall health, prior screening history and the patient's preferences. (2021) · USPSTF ↗ Note: Grade C reflects an individual decision rather than a blanket recommendation for or against. Applies to asymptomatic adults at average risk of colorectal cancer: no prior colorectal cancer, adenomatous polyps or inflammatory bowel disease, and no personal diagnosis or family history of a known genetic disorder that carries a high lifetime risk, such as Lynch syndrome or familial adenomatous polyposis.
Recommended (grade A/B)The USPSTF recommends that clinicians prescribe a statin for the primary prevention of cardiovascular disease for adults aged 40 to 75 years who have 1 or more cardiovascular risk factors and an estimated 10-year cardiovascular risk of 10% or greater. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for the cholesterol test; the USPSTF does not grade cholesterol testing on its own. The USPSTF says the ACC/AHA Pooled Cohort Equations may be used to estimate 10-year risk; per the 2013 ACC/AHA risk-assessment guideline, those equations use total and HDL cholesterol as inputs. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
Selective (grade C)The USPSTF recommends that clinicians selectively offer a statin for the primary prevention of cardiovascular disease for adults aged 40 to 75 years who have 1 or more cardiovascular risk factors and an estimated 10-year cardiovascular risk of 7.5% to less than 10%. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for the cholesterol test; the USPSTF does not grade cholesterol testing on its own. The USPSTF says the ACC/AHA Pooled Cohort Equations may be used to estimate 10-year risk; per the 2013 ACC/AHA risk-assessment guideline, those equations use total and HDL cholesterol as inputs. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of starting a statin for the primary prevention of cardiovascular disease in adults 76 years or older. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for the cholesterol test; the USPSTF does not grade cholesterol testing on its own. The USPSTF says the ACC/AHA Pooled Cohort Equations may be used to estimate 10-year risk; per the 2013 ACC/AHA risk-assessment guideline, those equations use total and HDL cholesterol as inputs. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for thyroid dysfunction in nonpregnant, asymptomatic adults. (2015) · USPSTF ↗ Note: The I statement concerns screening for thyroid dysfunction, for which the USPSTF names serum TSH as the primary screening test; T4 is described as follow-up testing after a persistently abnormal TSH.
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for bladder cancer in asymptomatic adults. (2011) · USPSTF ↗ Note: The USPSTF lists urine dipstick or microscopic urinalysis for hematuria (blood in the urine) among the bladder cancer screening tests it considered. This note covers only that use of a urinalysis.
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for impaired visual acuity in older adults. (2022) · USPSTF ↗
General preparation notes for 15 tests in this package

This is general information about how the exam is usually done, not medical advice for you or your family member. Requirements vary by center and by individual health history — always follow the center's own instructions and your own doctor's guidance, especially for any medicine change.

Body composition analysis

Mention when booking: Mention a pacemaker or implanted defibrillator: the test passes a weak electric current through the body and has traditionally not been recommended with these devices.

Total cholesterol

Fasting for 9 to 12 hours (no food or drink except plain water) is often requested, so the test is often done in the morning.

Mention when booking: Confirm with the center whether your test needs fasting; if you take insulin or other diabetes medicine, ask the prescribing doctor how to manage it while fasting.

Triglycerides

Fasting for 9 to 12 hours (no food or drink except plain water) is often requested.

Mention when booking: Confirm with the center whether your test needs fasting; if you take insulin or other diabetes medicine, ask the prescribing doctor how to manage it while fasting.

Fasting glucose

Usually needs at least 8 hours without food or drink except water beforehand.

Mention when booking: If you take insulin or other diabetes medicine, ask the prescribing doctor how to manage it while fasting, and mention it to the center.

Fasting insulin

Usually needs 8 to 12 hours of fasting (no food or drink except plain water) beforehand.

Mention when booking: Mention biotin (vitamin B7) supplements, usually paused for at least a day before this test, and any diabetes medicine; ask the prescribing doctor before changing any medicine.

Stool occult blood (FIT)

Guaiac-based kits usually ask you to avoid red meat, NSAIDs and more than 250mg of vitamin C for a few days beforehand; FIT kits usually need no diet change.

Mention when booking: Tell the center which kit you were given, and ask the prescribing doctor before stopping aspirin taken for the heart.

Urinalysis

Usually needs a clean-catch (midstream) sample; some tests instead ask you to collect all urine passed over 24 hours.

Mention when booking: Ask which specific urine test your provider ordered, since collection instructions vary by test.

Abdominal ultrasound

Usually needs about 6 hours without food beforehand; clear fluids other than milk or fizzy drinks are commonly still allowed. Loose, comfortable clothing is easiest.

Mention when booking: Mention if you have type 1 diabetes, so the center can offer an early appointment time.

Pelvic (gynecologic) ultrasound

For a transabdominal scan, drinking water beforehand to fill the bladder is common; for a transvaginal scan, an empty bladder is usual instead.

Mention when booking: Tell the center which type of scan you expect, and mention if you are, or might be, pregnant.

Prostate ultrasound

Usually needs little or no preparation; an enema and antibiotics are mainly for a planned biopsy. A scan through the lower belly instead may need a full bladder.

Mention when booking: Mention aspirin or other blood thinners; if a biopsy is planned, the center may ask about pausing them, so ask the prescribing doctor before changing any medicine.

Low-dose chest CT

Usually needs no fasting and no contrast injection; loose clothing with no metal is easiest.

Mention when booking: Tell the center if you are, or might be, pregnant.

Abdominal MRI / MRCP

Guidelines on eating vary by center; some ask for a short fast before an abdominal MRI or MRCP. Expect to hold your breath at times during the scan.

Mention when booking: Mention a pacemaker or other implanted device, metal fragments, pregnancy, kidney disease, or claustrophobia.

Afterwards: If you take a sedative for claustrophobia or anxiety, you'll need someone to take you home; arrange this before the scan.

Pap smear

Usually asks that you avoid intercourse, douching and tampons for 24 hours beforehand, and avoid scheduling during your period if possible.

Mention when booking: Tell the center if you are having unexpected bleeding, think you might be pregnant, or have had an abnormal Pap or positive HPV test before.

Afterwards: Light bleeding or spotting afterward is common and usually stops within a few hours.

Mammography

Usually asks that you skip deodorant, powder or lotion on the underarms and breasts, since these can look like calcium spots on the image. Bring prior mammograms from elsewhere if you have them.

Mention when booking: Mention breast implants, any breast symptoms, prior breast surgery, hormone use, or the possibility of pregnancy.

Afterwards: You may be asked to wait until the radiologist confirms the images are complete; ask when to expect results.

Bone density (DXA)

Usually asks that you skip calcium supplements for 24 hours beforehand. Avoid clothing with metal zippers or buttons, and remove jewelry.

Mention when booking: Mention any recent barium exam or CT/nuclear-medicine contrast, and whether pregnancy is possible.

Sources
As published by the hospital · checked 2026-09-20

How we collect and check these prices: see who we are and where the data comes from.

US$ at 32.1 TWD, 23 Sep 2026; you pay in NT$.
Upper Abdominal Health Screening Package
US$1,402
Book this checkup

If this isn't quite right

Other packages at Eonway Health Management Center

PackageTestsPrice
Civil Servant ProgramCivil-servant58
US$498
NT$16,000
Digestive Health Screening Package70
US$1,121
NT$36,000
Lung Health Screening Package72
US$1,121
NT$36,000
Cardiac Health Screening Package72
US$2,056
NT$66,000
Brain Health Screening Package67
US$2,368
NT$76,000
Tumor Screening Package (1-day)/(2-day)75
US$2,461
NT$79,000
CEO Health Screening Package78
US$4,611
NT$148,000
CEO Plus Health Screening Package84
US$5,607
NT$180,000

All packages at Eonway Health Management Center →

Similar packages in Taipei

Same tier, other hospitals in Taipei, closest in price first.
PackageHospitalTestsPrice
Brain Protection Program - Upgraded VersionNational Taiwan University Cancer Center38
US$1,116
NT$35,827
Brain Health ProgramTaiwan Adventist Hospital Health Management Center46
US$1,053
NT$33,800

All checkups in Taipei →

US$ at 32.1 TWD, 23 Sep 2026; you pay in NT$.

Browse: Cancer screening · Stomach and colon · Lung · All checkups in Taipei · What a checkup costs in Taiwan